User:Mr. Ibrahem/Remimazolam

Remimazolam, sold under the brand name Byfavo, is a medication used for procedural sedation. Specifically it is used in adults for procedures lasting less than 30 minutes. It is given by injection into a vein. While onset of effects is similar, the duration is shorter than midazolam.

Common side effects include low blood pressure, high blood pressure, and low oxygen. Other side effects may include abuse and allergic reactions. Effectiveness is not altered in kidney problems, though lower doses may be used in those with liver problems. Effects can be revered with flumazenil. It is a benzodiazepine and works by attaching to gamma-amino butyric acid (GABA) receptors.

Remimazolam was approved for medical use in the United States in 2020 and Europe in 2021. In the United States a vial of 20 mg costs about 42 USD as of 2022.